You are here

Industry Trends

Panel wants to know whether pharma companies contributed to opioid epidemic
Health care CEOs look for solutions
New patent battle focuses on Sovaldi, which costs thousands of dollars for a course
Senators complain about drug makers’ abuses
Former FDA heads say imported medications are too risky
Amgen and Illumina take Obamacare repeal in stride
Budget blueprint trims NIH biomed spending by 20%
Department of Health and Human Services feels the pinch
America’s elderly population expected to grow by 55%
New administrator offers extensive Medicaid experience
Candidate has strong ties to pharma industry
Academic centers offer bee venom for fibromyalgia and herbal remedies for Alzheimer’s